313 related articles for article (PubMed ID: 26486124)
21. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
Lee GC; Lawson KA; Burgess DS
Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
[TBL] [Abstract][Full Text] [Related]
22. Carbapenem-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.
Grome HN; Grass JE; Duffy N; Bulens SN; Ansari U; Campbell D; Lutgring JD; Gargis AS; Masters T; Kent AG; McKay SL; Smith G; Wilson LE; Vaeth E; Evenson B; Dumyati G; Tsay R; Phipps E; Flores K; Wilson CD; Czaja CA; Johnston H; Janelle SJ; Lynfield R; O'Malley S; Vagnone PS; Maloney M; Nadle J; Guh AY
Emerg Infect Dis; 2024 Jun; 30(6):1104-1114. PubMed ID: 38781979
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
24. Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12.
Robert J; Pantel A; Mérens A; Lavigne JP; Nicolas-Chanoine MH;
J Antimicrob Chemother; 2014 Oct; 69(10):2706-12. PubMed ID: 24942333
[TBL] [Abstract][Full Text] [Related]
25. Enterobacteriaceae infections of very low birth weight infants in Polish neonatal intensive care units: resistance and cross-transmission.
Wójkowska-Mach J; Chmielarczyk A; Borszewska-Kornacka M; Domańska J; Gadzinowski J; Gulczyńska E; Nowiczewski M; Helwich E; Kordek A; Pawlik D; Jursa-Kulesza J; Giedrys-Kalemba S; Szczapa J; Heczko PB
Pediatr Infect Dis J; 2013 Jun; 32(6):594-8. PubMed ID: 23411624
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
Baran I; Aksu N
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.
Guh AY; Limbago BM; Kallen AJ
Expert Rev Anti Infect Ther; 2014 May; 12(5):565-80. PubMed ID: 24666262
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates.
Sahin K; Tekin A; Ozdas S; Akin D; Yapislar H; Dilek AR; Sonmez E
Ann Clin Microbiol Antimicrob; 2015 Oct; 14():44. PubMed ID: 26444537
[TBL] [Abstract][Full Text] [Related]
29. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
Eibach D; Belmar Campos C; Krumkamp R; Al-Emran HM; Dekker D; Boahen KG; Kreuels B; Adu-Sarkodie Y; Aepfelbacher M; Park SE; Panzner U; Marks F; May J
Int J Med Microbiol; 2016 Jun; 306(4):249-54. PubMed ID: 27222489
[TBL] [Abstract][Full Text] [Related]
30. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
[TBL] [Abstract][Full Text] [Related]
31. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
[TBL] [Abstract][Full Text] [Related]
32. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
[TBL] [Abstract][Full Text] [Related]
33. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
[TBL] [Abstract][Full Text] [Related]
34. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals.
Lodise T; Ye MJ; Zhao Q
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559271
[TBL] [Abstract][Full Text] [Related]
36. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
Zhao ZC; Xu XH; Liu MB; Wu J; Lin J; Li B
Am J Infect Control; 2014 May; 42(5):e61-4. PubMed ID: 24773806
[TBL] [Abstract][Full Text] [Related]
37. Vital signs: carbapenem-resistant Enterobacteriaceae.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(9):165-70. PubMed ID: 23466435
[TBL] [Abstract][Full Text] [Related]
38. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
[TBL] [Abstract][Full Text] [Related]
39. Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
Prinapori R; Guinaud J; Khalil A; Lecuyer H; Gendrel D; Lortholary O; Nassif X; Viscoli C; Zahar JR
Am J Infect Control; 2013 Mar; 41(3):259-60. PubMed ID: 23062579
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]